Afreen Khanum

Ms. Afreen Khanum

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2026 in Proteomes
Verified
Journal Article
Open access
PDF file
AKAfreen Khanum
Afreen Khanum
LDLeona Dcunha
Leona Dcunha
SSSuhail Subair
Suhail Subair
AGAthira P G
Athira P G
APAkhina Palollathil
Akhina Palollathil
RRRajesh Raju
Rajesh Raju
Background: YES1 is an Src family non-receptor tyrosine-protein kinase that regulates cell growth, migration, survival, and oncogenic signaling. Although YES1 activation mechanisms and substrates have been extensively studied, its phosphosite-specific regulation across diverse biological contexts remains poorly understood. Methods: We performed a large-scale integrative analysis of 3825 publicly available human mass spectrometry-based phosphoproteomic datasets to map YES1 phosphorylation events. Co-modulation, co-occurrence, evolutionary conservation, and disease-association analyses were conducted to characterize the functional and clinical relevance of site-specific YES1 phosphorylation. Results: Y426 emerged as the predominant YES1 phosphosite across diverse biological conditions, localized within the activation loop of the kinase domain and conserved across Src family kinases. Co-modulation analysis identified 421 positively and 102 negatively associated phosphosites enriched in biological processes related to cell cycle regulation, transcription, cytoskeletal remodeling, apoptosis, and carcinogenesis. Among these high-confidence protein phosphosites, we identified 24 binary interactors, 5 upstream regulators, and 8 candidate downstream substrates. Comparison with DisGeNet cancer biomarkers showed overlap between YES1-associated phosphoproteomic signatures and site-specific oncogenic markers across multiple cancers, such as breast cancer, colorectal cancer, leukemia, and lung adenocarcinoma. Conclusions: This study provides a systems-level, phosphosite-focused view of YES1 signaling and supports a central regulatory role for Y426 within global phosphoregulatory and cancer-associated networks.

16 January 2026 in Integrative Biology
Verified
Journal Article
Closed access
VGVaishnavi Gopalakrishnan
Vaishnavi Gopalakrishnan
AMAlthaf Mahin
Althaf Mahin
AFAmal Fahma
Amal Fahma
AKAfreen Khanum
Afreen Khanum
SSSowmya Soman
Sowmya Soman
RRRajesh Raju
Rajesh Raju
Nuclear factor interleukin-3-regulated protein (NFIL3) is a transcription factor involved in the regulation of circadian rhythms and immune crosstalk. The transcriptional repressive and activational roles that influence cytokine expressions and tumor microenvironment have made NFIL3 a therapeutic target for several diseases. While protein-level functions of NFIL3 are widely explored, the molecular details regarding phospho-signals regulating NFIL3 and their functional significance are underexplored. To interpret the phosphoregulatory patterns of NFIL3, we conducted an extensive literature survey for mass-spectrometry-based cellular phosphoproteomics datasets with representation of NFIL3 phosphosites. From the compiled list of 656 cellular profiles and 116 datasets with differential expression, Ser301 and Ser353 of NFIL3 were identified as the predominant phosphosites, accounting for the majority of NFIL3 phosphosignals. Further, we explored the coregulated phosphosites in the interacting partners and transcription factors associated with NFIL3. With our integrative phosphoproteomics and the IL-4 dependent transcriptome dataset analysis, we report Ser301 and Ser353 as positively co-occurring phosphorylations in NFIL3 that essentially regulate its transcriptional activity. Further, we also unveil Mitogen-activated protein kinase 14 (MAPK14) as a high-confidence upstream kinase that can phosphorylate Ser301. This study identifies novel coregulation expression patterns and highlights regulatory phosphosites, establishing the foundation for future exploration of the NFIL3-associated dark phosphoproteome.